{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:05:24Z","timestamp":1773234324695,"version":"3.50.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/md.0000000000003360","type":"journal-article","created":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T18:33:10Z","timestamp":1462213990000},"page":"e3360","source":"Crossref","is-referenced-by-count":8,"title":["A Case Report"],"prefix":"10.1097","volume":"95","author":[{"given":"Bonnie Nga Kwan","family":"Choy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex Lap Ki","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer Wei Huen","family":"Shum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle Ching Yim","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy Shiu Ming","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-57-20210309","first-page":"663","article-title":"Skin pigmentation and corneal and lens opacities with prolonged chlorpromazine therapy","volume":"90","author":"Greiner","year":"1964","journal-title":"Canad Med Assoc J"},{"key":"R2-57-20210309","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00003226-200103000-00023","article-title":"Corneal deposition after high-dose chlorpromazine hydrochloride therapy","volume":"20","author":"Webber","year":"2001","journal-title":"Cornea"},{"key":"R3-57-20210309","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archophthalmol.2012.475","article-title":"Chlorpromazine-induced corneal toxicity","volume":"130","author":"Koh","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"R4-57-20210309","first-page":"247","article-title":"Chlorpromazine-induced skin pigmentation with corneal and lens opacities","volume":"93","author":"Huff","year":"2014","journal-title":"Cutis"},{"key":"R5-57-20210309","first-page":"502","article-title":"Chlorpromazine-induced corneal endothelial phototoxicity","volume":"22","author":"Hull","year":"1982","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-57-20210309","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-0447.1967.tb11024.x","article-title":"Lens opacities and porphobilinogen-like substance in urine associated with levomepromazine","volume":"43","author":"Kassman","year":"1967","journal-title":"Acta Psychiatr Scand"},{"key":"R7-57-20210309","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/jama.1965.03090010016003","article-title":"Lenticular and corneal opacities during phenothiazine therapy","volume":"193","author":"Barsa","year":"1965","journal-title":"JAMA"},{"key":"R8-57-20210309","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5694\/j.1326-5377.2009.tb02353.x","article-title":"Ocular pigmentation associated with clozapine","volume":"190","author":"Borovik","year":"2009","journal-title":"Med J Aust"},{"key":"R9-57-20210309","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/15569527.2015.1018387","article-title":"The ocular surface side effects of an anti-psychotic drug, clozapine","volume":"35","author":"Ceylan","year":"2016","journal-title":"Cutan Ocul Toxicol"},{"key":"R10-57-20210309","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/ICO.0b013e318124a42b","article-title":"In vivo observations of a case of chlorpromazine deposits in the cornea using an HRT II Rostock corneal module","volume":"26","author":"Toshida","year":"2007","journal-title":"Cornea"},{"key":"R11-57-20210309","first-page":"281","article-title":"Effects of promazine and chlorpromazine metabolites on the cornea","volume":"9","author":"Adams","year":"1974","journal-title":"Adv Biochem Psychopharmacol"},{"key":"R12-57-20210309","first-page":"173","article-title":"Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes","volume":"18","author":"Lal","year":"1993","journal-title":"J Psychiatry Neurosci"},{"key":"R13-57-20210309","first-page":"953","article-title":"Asymmetric anterior segment changes induced by chlorpromazine","volume":"13","author":"Deluise","year":"1981","journal-title":"Ann Ophthalmol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:22:10Z","timestamp":1620958930000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201604120-00057"}},"subtitle":["Anti-Psychotic Agents Related Ocular Toxicity"],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":13,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003360","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}